project id: TCGA-OV; case submitter id: TCGA-24-2036; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 7.8; spectrophotometer method: UV Spec; age at index: 50; days to birth: -18582; days to death: 1947; ethnicity: not reported; gender: female; race: white; vital status: Dead; year of birth: 1946; year of death: 2001; age at diagnosis: 18582; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1947.0; figo stage: Stage IIIA; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 1996; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 0.8; longest dimension: 1.1; preservation method: Unknown; shortest dimension: 0.4; sample id: 389cd452-fcf0-498b-9e65-7e28dbe8d5a4; sample submitter id: TCGA-24-2036-01A; portion id: e818506a-8fd5-4dda-8349-19c409dc7dab; portion submitter id: TCGA-24-2036-01A-01; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0;